Arabic PRO Measures for Head and Neck Cancer Radiotherapy.

Last updated: October 26, 2024
Sponsor: King Saud University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Oral Cancer

Oral Cavity Cancer

Neoplasms

Treatment

Radiation

Clinical Study ID

NCT06662929
E-23-7571
  • Ages > 18
  • All Genders

Study Summary

The goal of Arabic patient-reported outcome measures during radiotherapy for head and neck cancer is to test the patient-reported outcome measure (PROM) tools. PROM tools are not validated cross-culturally in Arabic-speaking patient populations, which limits their use in our clinical setting. Validation of these PROM tools will allow clinicians to identify the concerns related to our patient population and measure the outcome of our interventions. Main objectives are:

  • To further validate (cross-culture) the PROM instruments related to head and neck cancer (HNC) in Arabic patients.

  • To investigate the prevalence and severity of the patient-reported concerns and their relevance with demographics and clinical characteristics.

The participants will be given tasks to complete 6 tools survey before, during, and after radiotherapy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adults aged 18 or above and who is planned for receiving and who is currentlyreceiving and who had already received radiotherapy for the HNC at King SaudUniversity Medical City.

Exclusion

Exclusion Criteria:

  • Individuals who are less than 18 years, presence of debilitating disease (e.g. heartfailure) or who lack the capacity to read, understand and sign the informed consentand those.

Study Design

Total Participants: 125
Treatment Group(s): 1
Primary Treatment: Radiation
Phase:
Study Start date:
May 01, 2023
Estimated Completion Date:
October 01, 2025

Connect with a study center

  • King Saud University Medical City

    Riyadh,
    Saudi Arabia

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.